Acute Promyelocytic Leukemia

Incidence and onset information

Alternative names

Acute Promyelocytic Leukemia Is also known as acute myeloid leukemia with t(15;17)(q22;q12);(pml/raralpha) and variants, acute myeloblastic leukemia 3, apml, aml m3, aml with t(15;17)(q22;q12);(pml/raralpha) and variants, leukemia, acute promyelocytic.

Researches and researchers

Doctors, researchs, and experts related to Acute Promyelocytic Leukemia extracted from public data.

Acute Promyelocytic Leukemia Experts map

Current Researchs and researchers

• LEUVEN — Pr Peter A VANDENBERGHE

  Responsible for diagnostic tests - Investigator of research project
  
  

  • Institution/s:
    — Department of Human Genetics, University Hospitals Leuven - Gasthuisberg
  • Research area/topic::
    

    The role of RAS- and RHO-GTPases, their regulators and mediators in the pathogenesis of myeloid malignancies.



• DRESDEN — Pr Uwe PLATZBECKER

  Coordinator of expert centre - Clinical expert - Principal investigator of clinical trial - Investigator of research project
  
  

  • Institution/s:
    — Universitätsklinikum Carl Gustav Carus an der TU Dresden
    — Universitätsklinikum Carl Gustav Carus an der TU Dresden
  • Research area/topic::
    

    NAPOLEON Registry of the German AML Intergroup - National acute promyelocytic leukemia observational study



• MANNHEIM — Dr Susanne SAUßELE

  Coordinator of expert centre - Clinical expert - Principal investigator of clinical trial - Investigator of research project - Coordinator of research network
  
  

  • Institution/s:
    — III. Medizinische Universitäts-Klinik, Universitätsklinikum Mannheim
    — Universitätsmedizin Mannheim
  • Research area/topic::
    

    Competence Network 'acute and chronic leukemias'



• STUTTGART — Pr Jochen GREINER

  Investigator of research project
  
  

  • Institution/s:
    — Diakonie-Klinikum Stuttgart
  • Research area/topic::
    

    AMLSG 18-12: Maintenance therapy with Histamine Dihydrochloride and Interleukin-2 in adult AML patients with measurable minimal residual disease - a Non-interventional Study

Acute Promyelocytic Leukemia Recommended genes panels

Panel Name, Specifity and genes Tested/covered
Hereditary Endocrine Cancer Panel. By Baylor Miraca Genetics Laboratories (United States). SDHA, SDHB, SDHC, SDHD, TP53, VHL, CDC73, SDHAF2, TMEM127, MAX, MEN1, PRKAR1A, PTEN, RET Specificity 8 % Genes 3 %
Comprehensive Hereditary Cancer Panel. By Baylor Miraca Genetics Laboratories (United States). RUNX1, SDHA, SDHB, SDHC, SDHD, BMPR1A, BRCA1, BRCA2, STK11, EPCAM, TP53, VHL, WT1, CBL, SUFU, CDC73, CDH1, CDK4, CDKN1C, CDKN2A , (...) View the complete list with 39 more genes Panel complete gene list RUNX1, SDHA, SDHB, SDHC, SDHD, BMPR1A, BRCA1, BRCA2, STK11, EPCAM, TP53, VHL, WT1, CBL, SUFU, CDC73, CDH1, CDK4, CDKN1C, CDKN2A, CEBPA, SBDS, BRIP1, SDHAF2, TMEM127, PALB2, FLCN, ENG, FH, GATA2, ALK, GPC3, APC, SMAD4, MAX, MEN1, MET, MLH1, MRE11, MSH2, MSH6, MUTYH, NBN, NF2, ATM, PAX5, PMS1, PMS2, PHOX2B, PRF1, PRKAR1A, BARD1, PTCH1, PTEN, PTPN11, RAD50, RAD51C, RAD51D, RET Close Specificity 4 % Genes 6 %
Inherited Cancer Panel. By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States). BLM, SDHB, BMPR1A, BRCA1, BRCA2, STK11, EPCAM, TP53, TSC1, TSC2, VHL, XRCC2, CDC73, CDH1, CDK4, CDKN1B, CDKN2A, BRIP1, SDHAF2, TMEM127 , (...) View the complete list with 28 more genes Panel complete gene list BLM, SDHB, BMPR1A, BRCA1, BRCA2, STK11, EPCAM, TP53, TSC1, TSC2, VHL, XRCC2, CDC73, CDH1, CDK4, CDKN1B, CDKN2A, BRIP1, SDHAF2, TMEM127, PALB2, FLCN, FH, APC, SMAD4, MAX, MEN1, MET, MITF, MLH1, MRE11, MSH2, MSH6, MUTYH, NBN, NF1, ATM, PMS2, PRKAR1A, BAP1, BARD1, PTCH1, PTEN, RAD50, RAD51C, RAD51D, RB1, RET Close Specificity 3 % Genes 3 %
VistaSeq Hereditary Cancer Panel. By Molecular Diagnostic Laboratory University of Alberta (Canada). BMPR1A, BRCA1, BRCA2, STK11, EPCAM, TP53, CDH1, CDK4, CDKN2A, BRIP1, ABRAXAS1, PALB2, APC, SMAD4, MLH1, MSH2, MSH6, MUTYH, NBN, ATM , (...) View the complete list with 6 more genes Panel complete gene list BMPR1A, BRCA1, BRCA2, STK11, EPCAM, TP53, CDH1, CDK4, CDKN2A, BRIP1, ABRAXAS1, PALB2, APC, SMAD4, MLH1, MSH2, MSH6, MUTYH, NBN, ATM, PMS2, PRKAR1A, BARD1, PTEN, RAD51C, RAD51D Close Specificity 4 % Genes 3 %
Vistaseq Hereditary Cancer Panel Without BRCA. By Molecular Diagnostic Laboratory University of Alberta (Canada). BMPR1A, STK11, EPCAM, TP53, CDH1, CDK4, CDKN2A, BRIP1, ABRAXAS1, PALB2, APC, SMAD4, MLH1, MSH2, MSH6, MUTYH, NBN, ATM, PMS2, PRKAR1A , (...) View the complete list with 4 more genes Panel complete gene list BMPR1A, STK11, EPCAM, TP53, CDH1, CDK4, CDKN2A, BRIP1, ABRAXAS1, PALB2, APC, SMAD4, MLH1, MSH2, MSH6, MUTYH, NBN, ATM, PMS2, PRKAR1A, BARD1, PTEN, RAD51C, RAD51D Close Specificity 5 % Genes 3 %
VistaSeq Endrocrine Cancer Panel. By Molecular Diagnostic Laboratory University of Alberta (Canada). SDHB, SDHC, SDHD, TP53, VHL, CDC73, TMEM127, MAX, MEN1, NF1, PRKAR1A, PTEN, RET Specificity 8 % Genes 3 %
Hypoparathyroidism Deletion/Duplication Panel. By Genetic Services Laboratory University of Chicago (United States). STX16, TBCE, TBX1, CASR, CHD7, FAM111A, CYP24A1, AIRE, GATA3, GCM2, GNA11, GNAS, HADHA, HADHB, PDE4D, PRKAR1A, PTH Specificity 6 % Genes 3 %
Hypoparathyroidism sequencing panel. By Genetic Services Laboratory University of Chicago (United States). STX16, TBCE, TBX1, CASR, CDH7, FAM111A, CYP24A1, AIRE, GATA3, GCM2, GNA11, GNAS, HADHA, HADHB, PDE4D, PRKAR1A, PTH Specificity 6 % Genes 3 %

Sources and references

You can check the following sources for additional information.

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SEIZURES, BENIGN FAMILIAL INFANTILE, 5; BFIS5 RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME NEURAL TUBE DEFECTS, FOLATE-SENSITIVE; NTDFS MYOPATHY, DISTAL, 5; MPD5 MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY; MSCCA